Fierce Pharma

AbbVie’s Skyrizi takes full-year TV ad spending crown yet again

Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...
FiercePharma

AbbVie unveils new Skyrizi TV ads with a subtler tone compared to its revved-up Rinvoq approach

This year, AbbVie has continually been a big spender in the TV ad drug stakes, and it’s showing no signs of slowing down. After launching two new Rinvoq commercials this summer, the Big Pharma is now ...
MM&M

Skyrizi goes sky high, topping Rx and OTC brands in April

Skyrizi has knocked Dupixent off its pedestal and claimed the top spot for ad impressions by Rx and over-the-counter (OTC) brands in April. The treatment for Crohn’s disease, psoriasis and psoriatic ...
MM&M

AbbVie’s Skyrizi leads pharma TV ad rankings for April

AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...